Filtered By:
Cancer: Prostate Cancer
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 543 results found since Jan 2013.
CMS Releases Final Rule for Second Year of QPP - Includes PI-QI CME Improvement Activity
Last week, the Centers for Medicare & Medicaid Services (CMS) released a final rule that makes changes in the second year of the Quality Payment Program (QPP) under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), including the Merit-based Incentive Program (MIPS) and Advanced Payment Models (APMs). The second year of the QPP continues to build on transitional year 1 policies, noting that a “second year to ramp-up the program will continue to help build upon the iterative learning and development of year 1 in preparation for a robust program in year 3.”
In addition to the final rule, CMS als...
Source: Policy and Medicine - November 6, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
CMS Releases Final Rule for Second Year of QPP
Last week, the Centers for Medicare & Medicaid Services (CMS) released a final rule that makes changes in the second year of the Quality Payment Program (QPP) under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), including the Merit-based Incentive Program (MIPS) and Advanced Payment Models (APMs). The second year of the QPP continues to build on transitional year 1 policies, noting that a “second year to ramp-up the program will continue to help build upon the iterative learning and development of year 1 in preparation for a robust program in year 3.”
In addition to the final rule, CMS als...
Source: Policy and Medicine - November 6, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Sepsis: The Body ’s Deadly Response to Infection
Your browser does not support iframes.
Although not as well-known as other medical conditions, sepsis kills more people in the United States than AIDS, breast cancer, or prostate cancer combined. Sepsis is body-wide inflammation, usually triggered by an overwhelming immune response to infection. Though doctors and medical staff are well-aware of the condition—it is involved in 1 in 10 hospital deaths—the condition is notoriously hard to diagnose. In this video, sepsis expert Sarah Dunsmore, a program director with the National Institute of General Medical Sciences (NIGMS), describes what sepsis is and how to recognize ...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - November 2, 2017 Category: Research Authors: Chris Palmer Tags: Physical Trauma and Sepsis Source Type: blogs
Study investigates treatment regret among prostate cancer survivors
As they get older, do men with prostate cancer come to regret the treatment decisions they made? A new study of men diagnosed during the mid-1990s indicates that some of them will.
Richard Hoffman, a professor of internal medicine and epidemiology at the University of Iowa Carver College of Medicine in Iowa City, led a team that reviewed survey data that men filled out one, two, five, and 15 years after they were treated for prostate cancer. All 934 men included in the study were 75 or younger when diagnosed, each with localized tumors confined to the prostate gland. Approximately 60% of the men had low-risk prostate cance...
Source: Harvard Health Blog - October 20, 2017 Category: Consumer Health News Authors: Charlie Schmidt Tags: Cancer Men's Health Prostate Health Source Type: blogs
Time to rethink the debate on PSA testing
For most of us, whether to screen for cancer is a no-brainer. Who wouldn’t want a simple test to prevent cancer or identify it at an earlier, more treatable stage? However, as with many things, the screening decision is more complex than it may appear. For example, the test may not be particularly “simple,” such as undergoing screening colonoscopy. For prostate cancer, even after 30-plus years of using a screening blood test called the prostate specific antigen, or PSA, it still isn’t clear how well it prevents prostate cancer deaths. This has led to conflicting and changing recommendations about whether to screen ...
Source: Harvard Health Blog - September 29, 2017 Category: Consumer Health News Authors: Steven J. Atlas, MD, MPH Tags: Cancer Health Men's Health Prostate Health Source Type: blogs
We Can Improve Care Management
As a physician and CIO, I ’m quick to spot inefficiencies in healthcare workflow. More importantly, as the care navigator for my family, I have extensive firsthand experience with patient facing processes.My wife ’s cancer treatment, my father’s end of life care, and my own recent primary hypertension diagnosis taught me how we can do better.Last week, when my wife received a rejection in coverage letter from Harvard Pilgrim/Caremark, it highlighted the imperative we have to improve care management workflow in the US.Since completing her estrogen positive, progesterone positive, HER2 negative breast cancer treat...
Source: Life as a Healthcare CIO - September 12, 2017 Category: Information Technology Source Type: blogs
Photoacoustics Measures Oxygenation of Tumors to Help Choose Treatment
Different tumors respond differently to radiation and chemotherapy. There’s a lot of evidence that solid tumors that are poorly oxygenated don’t respond well to these therapies. So having a way to assess tumors for tissue oxygenation can ...
Source: Medgadget - August 29, 2017 Category: Medical Devices Authors: Editors Tags: Oncology Radiology Source Type: blogs
How Does a BRCA Genetic Test Work? – The Dante Labs Review
Dante Labs offered me their BRCA genetic test, which I gladly accepted as I never had an evaluation focused on my BRCA1 and BRCA2 genes. These are very important as their mutations increase the risk of breast cancer and ovarian cancer in women, and prostate cancer in men. Here is my verdict.
The Angelina effect and why BRCA genes matter
The concept and practice of BRCA genetic testing became extremely popular after Hollywood actress Angelina Jolie publicized her results in 2013 alongside her decision to undergo a double mastectomy. A merciless but effective way to avoid getting breast cancer. Researchers even found that ...
Source: The Medical Futurist - August 29, 2017 Category: Information Technology Authors: nora Tags: Genomics cancer gc3 genes Genetic testing genetics Health Healthcare Innovation personalized genetics Personalized medicine Source Type: blogs
Strong study shows no link between vasectomy and prostate cancer
In the 1980s, reports began to surface of a potential connection between vasectomies and prostate cancer. This worried men considering vasectomies for birth control, but it was also controversial. Some studies detected an association while others didn’t. Harvard Prostate Knowledge last covered the topic in 2015, after the largest study to that point detected slightly higher risks of high-grade prostate cancer among men who had a vasectomy compared to men who hadn’t.
Now that study has been eclipsed by an even larger one.
Here’s how the analysis worked
For this new effort, researchers with the Mayo Clinic in Rochester...
Source: Harvard Health Blog - August 23, 2017 Category: Consumer Health News Authors: Charlie Schmidt Tags: Family Planning and Pregnancy Prostate Health Source Type: blogs
Combination hormonal therapy boosts survival in men with aggressive prostate cancer
A standard approach for treating aggressive prostate cancer is to give therapies that block testosterone, a tumor-stimulating hormone. Should initial hormonal therapies fail, doctors can switch to other drugs that suppress testosterone in different ways. One of them, a drug called abiraterone, has been shown to significantly extend lifespans in men who have become resistant to other hormonal treatments.
But in June, two major studies reported simultaneously that abiraterone also prolongs life in men with aggressive prostate cancer that’s been newly diagnosed. One of the studies, a phase 3 clinical trial called LATITUDE, ...
Source: Harvard Health Blog - August 18, 2017 Category: Consumer Health News Authors: Charlie Schmidt Tags: Cancer Health Men's Health Prostate Health Source Type: blogs
Yoga improves treatment-related symptoms in men with prostate cancer
Decades of research show that yoga can reduce the emotional and physical fatigue brought on by cancer treatment. Now researchers have shown for the first time that’s also true specifically for men being treated for prostate cancer. Men who took a yoga class twice a week during treatment reported less fatigue, fewer sexual side effects, and better urinary functioning than men who did not, according a new study. “The data are convincing,” said the study’s principal investigator, Dr. Neha Vapiwala, an associate professor of radiation oncology at the University of Pennsylvania School of Medicine in Philadelphia. “Wha...
Source: Harvard Health Blog - August 4, 2017 Category: Consumer Health News Authors: Charlie Schmidt Tags: Cancer Complementary and alternative medicine Prostate Health Yoga Source Type: blogs
Vitamin K and Osteoporosis — What ’ s the connection?
Before you are prescribed bisphosphonates: Fosamax, Actonel, Boniva, Reclast or Zometa, maybe you should consider the Undoctored strategy.
The grain-free diet, vitamin D, and magnesium protocols in the core Undoctored program provide the bulk of bone health benefits through a variety of mechanisms, including increased intestinal calcium absorption, reduced urinary calcium loss, and reduced levels of the parathyroid hormone that weakens bones.
You should also avoid calcium supplements, as the effects of vitamin D and the increased intestinal calcium absorption that develops after eliminating calcium-binding phytates from gr...
Source: Wheat Belly Blog - August 1, 2017 Category: Cardiology Authors: Dr. Davis Tags: Undoctored Vitamin K Wheat Belly Lifestyle anti-aging bowel flora Dr. Davis gluten-free grain-free health osteopenia osteoporosis Wheat Belly Total Health Source Type: blogs
Cancer patients can ’t afford care
Lost in the debate on “Trumpcare” versus “Obamacare” is the proper consideration of the factors driving increasing health care costs. In cancer, the pharmaceutical industry plays a major role setting drug prices that exceed reasonable returns on research and development. The economics of treatment were again apparent during the plenary session of the American Society of Clinical Oncology Annual Meeting in June, aka the cancer community’s Super Bowl. Two years ago, Dr. Leonard Saltz of Memorial Sloan Kettering implored us to pay attention to the cost of drugs being presented, emphasizing during the plenary session...
Source: Kevin, M.D. - Medical Weblog - July 28, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/syed-m-ahmed" rel="tag" > Syed M. Ahmed, MD, PhD < /a > Tags: Physician Cancer Source Type: blogs
Should we screen African-American men for prostate cancer?
Regular readers of my blog know that I believe that the harms of prostate-specific antigen (PSA) screening for prostate cancer outweigh the benefits — if benefits exist at all. That isn’t to say that I will not order the test in a man who understands the risks and expresses a clear preference to be screened. In a recent editorial in American Family Physician, I explained my approach to counseling patients about potential screening harms:
Many older men, especially those who have received PSA tests in the past, may be surprised to learn that screening is no longer routine. Primary care physicians should anticipate t...
Source: Kevin, M.D. - Medical Weblog - July 23, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/kenneth-lin" rel="tag" > Kenneth Lin, MD < /a > Tags: Conditions Cancer Source Type: blogs
